title: [New approaches to therapy of Helicobacterpylori infection (by the materials of the Maastricht Consensus-IV, Florence, 2010)].
abstract: European recommendations for eradication of Helicobacter pylori are presented. The increase of the resistance to clarithromycin requires the necessity of rational use of quadritherapy as the first line treatment and sequential therapy including drugs active against the pathogen with low resistance. New treatment regiments for patients with allergy to penicillin are recommended.
authors.forename: A G
authors.initials: AG
authors.lastname: Evdokimova
authors.forename: L V
authors.initials: LV
authors.lastname: Zhukolenko
authors.forename: V V
authors.initials: VV
authors.lastname: Evdokimov
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D003245:Consensus Statements as Topic; D004342:Drug Hypersensitivity / Q000517:prevention & control; D024881:Drug Resistance, Bacterial / Q000187:drug effects*; D004359:Drug Therapy, Combination / Q000379:methods; D017408:Guidelines as Topic; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D007558:Italy; D010406:Penicillins / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D010406:Penicillins; D017291:Clarithromycin